The EVADIAC association (EVAluation dans le Diabète des Implants ACtifs) was created in 1990 in Cassis, France, at the beginning of implanted insulin pump treatment in France. In fact the first four centers (Strasbourg, Marseille, Montpellier, Toulouse) experiencing the treatment by continous intraperitoneal insulin infusion with implantable pumps (CIPII) derided to join in a group with the primary objective to monitor the safety of the technique. The founding members built the statutes of EVADIAC and the goals were defined as: • Collecting and spreading all the required elements in order to assess the quality of the diabetes treatment by active implants. • Evaluating the benefits of such a treatment in patients with diabetes in order to improve its use. • Promoting every study and research about this kind of treatment. • Communicating with all the related national and international organizations. Due to the impulse of the first president, Ph. Vague, and his successors (M. Pinget, J.P. Tauber, J.L. Selam, V. Lassmann-Vague, E. Renard, H. Hanaire-Broutin), the group enlarged and gathers now 14 centers: Bordeaux, Corbeil, Dijon, Le Mans, Lille, Lyon, Marseille, Montpellier, Paris, Reims, Rennes. St Etienne, Strasbourg, Toulouse. The energy and enthusiasm of all EVADSAC members have allowed a large development and a broad experience of insulin implanted pumps treatment in France.